DE69930648D1 - Orale darreichungsform für pyridin-2-ylmethylsulfinyl-1h-benzimidazole - Google Patents

Orale darreichungsform für pyridin-2-ylmethylsulfinyl-1h-benzimidazole

Info

Publication number
DE69930648D1
DE69930648D1 DE69930648T DE69930648T DE69930648D1 DE 69930648 D1 DE69930648 D1 DE 69930648D1 DE 69930648 T DE69930648 T DE 69930648T DE 69930648 T DE69930648 T DE 69930648T DE 69930648 D1 DE69930648 D1 DE 69930648D1
Authority
DE
Germany
Prior art keywords
ylmethylsulfinyl
benzimidazole
pyridine
oral pharmaceutical
pharmaceutical form
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69930648T
Other languages
English (en)
Other versions
DE69930648T2 (de
Inventor
Rango Dietrich
Hartmut Ney
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda GmbH
Original Assignee
Byk Gulden Lomberg Chemische Fabrik GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8232445&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69930648(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Byk Gulden Lomberg Chemische Fabrik GmbH filed Critical Byk Gulden Lomberg Chemische Fabrik GmbH
Publication of DE69930648D1 publication Critical patent/DE69930648D1/de
Application granted granted Critical
Publication of DE69930648T2 publication Critical patent/DE69930648T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE69930648T 1998-08-12 1999-08-07 Orale darreichungsform für pyridin-2-ylmethylsulfinyl-1h-benzimidazole Expired - Lifetime DE69930648T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP98115141 1998-08-12
EP98115141 1998-08-12
PCT/EP1999/005724 WO2000009092A1 (en) 1998-08-12 1999-08-07 Oral administration form for pyridin-2-ylmethylsulfinyl-1h-benzimidazoles

Publications (2)

Publication Number Publication Date
DE69930648D1 true DE69930648D1 (de) 2006-05-18
DE69930648T2 DE69930648T2 (de) 2006-12-21

Family

ID=8232445

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69930648T Expired - Lifetime DE69930648T2 (de) 1998-08-12 1999-08-07 Orale darreichungsform für pyridin-2-ylmethylsulfinyl-1h-benzimidazole

Country Status (12)

Country Link
US (3) US7041313B1 (de)
EP (1) EP1105105B1 (de)
JP (1) JP4988088B2 (de)
AT (1) ATE321538T1 (de)
AU (2) AU772726B2 (de)
CA (2) CA2507743C (de)
DE (1) DE69930648T2 (de)
DK (1) DK1105105T3 (de)
ES (1) ES2262335T3 (de)
PT (1) PT1105105E (de)
SI (1) SI1105105T1 (de)
WO (1) WO2000009092A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US6489346B1 (en) 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
SE9902386D0 (sv) * 1999-06-22 1999-06-22 Astra Ab New formulation
WO2002032324A2 (en) * 2000-10-18 2002-04-25 Tyco Healthcare Group Lp Anastomosis instrument and method for performing same
SE0101379D0 (sv) 2001-04-18 2001-04-18 Diabact Ab Komposition som hämmar utsöndring av magsyra
US7241302B2 (en) 2001-10-18 2007-07-10 Tyco Healthcare Group Lp Anastomosis instrument and method for performing same
GB0209265D0 (en) * 2002-04-23 2002-06-05 Novartis Ag Organic compounds
MY148805A (en) 2002-10-16 2013-05-31 Takeda Pharmaceutical Controlled release preparation
SE0203065D0 (sv) 2002-10-16 2002-10-16 Diabact Ab Gastric acid secretion inhibiting composition
JP2004231520A (ja) * 2003-01-28 2004-08-19 Nichiko Pharmaceutical Co Ltd 保存安定性及び溶出速度に優れた医薬組成物
CL2004000983A1 (es) 2003-05-08 2005-03-04 Altana Pharma Ag Composicion farmaceutica oral en forma de tableta que comprende a pantoprazol magnetico dihidratado, en donde la forma de tableta esta compuesto por un nucleo, una capa intermedia y una capa exterior; y uso de la composicion farmaceutica en ulceras y
PE20050150A1 (es) 2003-05-08 2005-03-22 Altana Pharma Ag Una forma de dosificacion que contiene (s)-pantoprazol como ingrediente activo
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
TWI372066B (en) * 2003-10-01 2012-09-11 Wyeth Corp Pantoprazole multiparticulate formulations
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
JP5563735B2 (ja) 2004-06-16 2014-07-30 タケダ ファーマシューティカルズ ユー．エス．エー． インコーポレイティド Ｐｐｉ多回剤形
US11096948B2 (en) 2016-01-21 2021-08-24 Dexcel Pharma Technologies Ltd. Methods for treating helicobacter infection

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7804231L (sv) 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
IL75400A (en) 1984-06-16 1988-10-31 Byk Gulden Lomberg Chem Fab Dialkoxypyridine methyl(sulfinyl or sulfonyl)benzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing the same
JPS6150978A (ja) * 1984-08-16 1986-03-13 Takeda Chem Ind Ltd ピリジン誘導体およびその製造法
AU4640985A (en) 1984-08-31 1986-03-06 Nippon Chemiphar Co. Ltd. Benzimidazole derivatives
JPS61100526A (ja) * 1984-10-22 1986-05-19 Kyowa Hakko Kogyo Co Ltd 持続性ドパミン経黒剤
GB2189698A (en) * 1986-04-30 1987-11-04 Haessle Ab Coated omeprazole tablets
GB2189699A (en) 1986-04-30 1987-11-04 Haessle Ab Coated acid-labile medicaments
JPS6339814A (ja) * 1986-08-01 1988-02-20 Teisan Seiyaku Kk トラニラストの経口用持続性製剤
FI90544C (fi) 1986-11-13 1994-02-25 Eisai Co Ltd Menetelmä lääkeaineina käyttökelpoisten 2-pyridin-2-yyli-metyylitio- ja sulfinyyli-1H-bensimidatsolijohdannaisten valmistamiseksi
JP2602518B2 (ja) 1988-01-27 1997-04-23 エーザイ株式会社 被覆された胃酸分泌抑制剤含有組成物
DE3822095A1 (de) * 1988-06-30 1990-01-04 Klinge Co Chem Pharm Fab Neue arzneimittelformulierung sowie verfahren zu deren herstellung
US5149702A (en) 1989-11-29 1992-09-22 Toa Eiyo Ltd. Cycloheptenopyridine derivatives, process for preparation thereof and antiulcer agents containing the same
US5229131A (en) * 1990-02-05 1993-07-20 University Of Michigan Pulsatile drug delivery system
KR930006431B1 (ko) * 1990-10-11 1993-07-16 재단법인 한국화학연구소 약물의 미세캡슐화 방법
YU48263B (sh) 1991-06-17 1997-09-30 Byk Gulden Lomberg Chemische Fabrik Gmbh. Postupak za dobijanje farmaceutskog preparata na bazi pantoprazola
IT1251153B (it) * 1991-08-06 1995-05-04 Vectorpharma Int Composizioni farmaceutiche solide per somministrazione orale aventi proungata residenza gastrica
US5260068A (en) * 1992-05-04 1993-11-09 Anda Sr Pharmaceuticals Inc. Multiparticulate pulsatile drug delivery system
FR2692146B1 (fr) * 1992-06-16 1995-06-02 Ethypharm Sa Compositions stables de microgranules d'omeprazole gastro-protégés et leur procédé d'obtention.
WO1994002140A1 (en) 1992-07-17 1994-02-03 Astra Aktiebolag Pharmaceutical composition containing antiulcer agent
US5260069A (en) * 1992-11-27 1993-11-09 Anda Sr Pharmaceuticals Inc. Pulsatile particles drug delivery system
JPH0710758A (ja) * 1993-06-22 1995-01-13 Nippon Iyakuhin Kogyo Kk 持続性セファクロル製剤
SE9402431D0 (sv) 1994-07-08 1994-07-08 Astra Ab New tablet formulation
ES2094694B1 (es) * 1995-02-01 1997-12-16 Esteve Quimica Sa Nueva formulacion farmaceuticamente estable de un compuesto de bencimidazol y su proceso de obtencion.
SE9500478D0 (sv) 1995-02-09 1995-02-09 Astra Ab New pharmaceutical formulation and process
US5567441A (en) * 1995-03-24 1996-10-22 Andrx Pharmaceuticals Inc. Diltiazem controlled release formulation
US5945124A (en) * 1995-07-05 1999-08-31 Byk Gulden Chemische Fabrik Gmbh Oral pharmaceutical composition with delayed release of active ingredient for pantoprazole
SK284291B6 (sk) 1995-09-21 2005-01-03 Pharma Pass L.L.C. Farmaceutická kompozícia vo forme tabliet alebo mikrotabliet obsahujúca acidolabilný omeprazol a spôsob jej prípravy
US5840332A (en) * 1996-01-18 1998-11-24 Perio Products Ltd. Gastrointestinal drug delivery system
US6245351B1 (en) * 1996-03-07 2001-06-12 Takeda Chemical Industries, Ltd. Controlled-release composition
SE9602442D0 (sv) 1996-06-20 1996-06-20 Astra Ab Administration of pharmaceuticals
DE19626045C2 (de) 1996-06-28 1998-12-03 Klinge Co Chem Pharm Fab Stabile Arzneiform zur oralen Verabreichung, welche Omeprazol als aktiven Wirkstoff enthält, sowie Verfahren zur Herstellung derselben
US6623759B2 (en) * 1996-06-28 2003-09-23 Astrazeneca Ab Stable drug form for oral administration with benzimidazole derivatives as active ingredient and process for the preparation thereof
SE9704870D0 (sv) 1997-12-22 1997-12-22 Astra Ab New pharmaceutical formulation I
US6749867B2 (en) * 2000-11-29 2004-06-15 Joseph R. Robinson Delivery system for omeprazole and its salts

Also Published As

Publication number Publication date
CA2507743A1 (en) 2000-02-24
WO2000009092A1 (en) 2000-02-24
CA2340054C (en) 2005-10-18
US7402321B2 (en) 2008-07-22
DK1105105T3 (da) 2006-07-17
JP4988088B2 (ja) 2012-08-01
SI1105105T1 (sl) 2006-08-31
EP1105105B1 (de) 2006-03-29
ATE321538T1 (de) 2006-04-15
AU5511499A (en) 2000-03-06
DE69930648T2 (de) 2006-12-21
AU2004202162B2 (en) 2007-03-08
EP1105105A1 (de) 2001-06-13
PT1105105E (pt) 2006-07-31
US20060263426A1 (en) 2006-11-23
AU772726B2 (en) 2004-05-06
US8465767B2 (en) 2013-06-18
CA2340054A1 (en) 2000-02-24
AU2004202162A1 (en) 2004-06-17
ES2262335T3 (es) 2006-11-16
US7041313B1 (en) 2006-05-09
US20080226712A1 (en) 2008-09-18
CA2507743C (en) 2008-03-18
JP2002522472A (ja) 2002-07-23

Similar Documents

Publication Publication Date Title
DE69930648D1 (de) Orale darreichungsform für pyridin-2-ylmethylsulfinyl-1h-benzimidazole
AR034691A1 (es) Composiciones farmaceuticas de administracion oral, que contiene un inhibidor de lipasa gastrointestinal, el comprimido masticable y la galleta que los comprende
TR200200579T2 (tr) Amino-tirazolpiridin türevleri.
ATE297203T1 (de) Antithrombotische mitteln
ATE306261T1 (de) Antithrombosemittel
PT1109812E (pt) Pirrolobenzodiazepinas
DE60142891D1 (de) Azetidinderivate enthaltende pharmazeutische zusammensetzungen, die azetidinderivate und deren herstellung
SE9504661D0 (sv) New compounds
TR200000722T2 (tr) Silikatlı küçük kristalli selüloz içeren farmakolojik ilaç.
HUP9802999A2 (hu) N-propargil-1-amino-indánt tartalmazó gyógyszerkészítmény
BR0014651A (pt) Inibidores de adesão de célula mediada por "alfa" l beta2
BR0212386A (pt) Composto, formulação farmacêutica, e, uso de um composto
HUP0104647A2 (hu) Hatóanyagként tilidin-mezilátot tartalmazó, szabályozott hatóanyag-leadású gyógyszerkészítmény
SE9700885D0 (sv) New pharmaceutical formulation
DE60128100D1 (de) Analgetisches arzneimittel
NO20014855D0 (no) N-(2-fenyl-4-aminobutyl)-1-naftamider som neurokinin-1- reseptorantagonister
SE9504662D0 (sv) New compounds
DK0469440T3 (da) Faste orale applikationsformer, der som aktivt stof indeholder ifosamid
EP0816366A4 (de) Imidazothiazolverbindungen
ES2170168T3 (es) Composiciones recubiertas entericamente de derivados de 1,5-benzodiacepina con actividad antagonista o agonista de cck.
DE69635775D1 (de) Medikament gegen pulmonale herzprobleme
ATE268768T1 (de) Antithrombosemittel
PT1097145E (pt) Derivados de poli-hidroxialquilpirazina e sua preparacao e medicamentos que os contem
ECSP993102A (es) Composiciones farmaceuticas
HUP9902191A2 (hu) Az érképződést gátló anyag

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: ALTANA PHARMA AG, 78467 KONSTANZ, DE

8363 Opposition against the patent
8327 Change in the person/name/address of the patent owner

Owner name: NYCOMED GMBH, 78467 KONSTANZ, DE